Margetić Sandra, Ćelap Ivana, Dukić Lora, Vukasović Ines, Virović-Jukić Lucija
Clinical Institute of Chemistry, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
University Department of Internal Medicine, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
Biochem Med (Zagreb). 2016;26(2):248-54. doi: 10.11613/BM.2016.028.
The aim of this report was to present a case of interference on prothrombin time (PT) test that directed further laboratory diagnostics and resulted with final detection of monoclonal gammopathy in an 88-year old man. Routine coagulation testing during medical examination at Emergency Department revealed unmeasurable PT (< 7% activity) and activated partial thromboplastin time (aPTT) within reference range. After repeated sampling for coagulation testing, PT was unmeasurable again, as well as fibrinogen level (< 0.8 g/L), thrombin time (TT) was significantly prolonged (107 seconds) and aPTT was within reference range. In both plasma samples refrigerated at 4 ˚C overnight, white gelatinous precipitate was visible between the cell and plasma layers and the presence of monoclonal protein (M-protein) was suggested in our patient. Further laboratory diagnostics revealed total serum proteins at concentration of 123 g/L and the presence of M-protein IgG lambda (λ) at concentration of 47.1 g/L. These results suggested monoclonal gammopathy as an underlying pathophysiological condition in our patient. Activities of coagulation factors II, V, VII and X were within reference ranges or increased. These results and correction of unmeasurable PT result to 67% in mixing test with commercial normal plasma suggest in vitro rather than in vivo interference of M-protein on PT result. In contrast, significantly prolonged TT results in all analysed samples suggest impact of M-protein on this global coagulation test due to possible effect on fibrin polymerization.
本报告旨在介绍一例凝血酶原时间(PT)检测受干扰的病例,该干扰促使进一步的实验室诊断,并最终在一名88岁男性中检测出单克隆丙种球蛋白病。在急诊科体检期间进行的常规凝血检测显示PT无法测量(活性<7%),而活化部分凝血活酶时间(aPTT)在参考范围内。在重复进行凝血检测采样后,PT再次无法测量,纤维蛋白原水平也<0.8 g/L,凝血酶时间(TT)显著延长(107秒),而aPTT在参考范围内。在两个于4˚C冷藏过夜的血浆样本中,细胞层和血浆层之间可见白色凝胶状沉淀,提示我们的患者存在单克隆蛋白(M蛋白)。进一步的实验室诊断显示血清总蛋白浓度为123 g/L,存在浓度为47.1 g/L的M蛋白IgG λ(λ)。这些结果提示单克隆丙种球蛋白病是我们患者潜在的病理生理状况。凝血因子II、V、VII和X的活性在参考范围内或升高。这些结果以及在与商业正常血浆的混合试验中无法测量的PT结果校正至67%,提示M蛋白对PT结果存在体外而非体内干扰。相比之下,所有分析样本中TT显著延长提示M蛋白可能通过对纤维蛋白聚合的影响而对这一整体凝血试验产生影响。